Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Please help us personalize your experience.

Select the one that best describes you
  • ETF
  • FV
    Pricing Data
    Change: $0.11 (-0.0%)
    Time: 11/11/19
    Previous Close: $30.31
  • Category
  • All Cap Equities
Last Updated:



Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $23.25
  • 52 Week Hi: $31.35
  • AUM: $2,349.6 M
  • Shares: 77.7 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 209,209
  • 3 Month Avg. Volume: 190,924

Alternative ETFs in the All Cap Equities Category

Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest RENW $3.1 M 880 9.10%
Largest (AUM) SDY 0.35% $19,368.3 M 445,859 20.29%
Most Liquid (Volume) SDY 0.35% $19,368.3 M 445,859 20.29%
Top YTD Performer ALFA 0.65% $22.7 M 1,426 34.26%

Analyst Report

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for FV on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the All Cap Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

FV Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A n/a
Expenses C n/a

FV In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its Category.

FV Holdings

Filings Data as of: Nov 11, 2019

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group Category.

Number of Holdings
Rank: 81 of 84
Category Low NOCT (1)
Category High TILT (2217)
% Assets in Top 10
Rank: 83 of 84
Category Low EUSA (2.57%)
Category High DFND (115.96%)

Asset Allocation

Asset Percentage
Common equity 99.56%
ETF Cash Component 0.44%

Sector Breakdown

Sector Percentage
Technology 43.08%
Financials 14.81%
Communications 13.93%
Utilities 12.79%
Other 6.94%
Consumer, Cyclical 3.31%
Real Estate 3.21%
Healthcare 0.99%
Industrials 0.48%
ETF Cash Component 0.44%

Market Cap Breakdown

Market Cap Percentage
Large cap 49.66%
Mid cap 32.58%
Small cap 16.25%
Micro cap 0.88%
ETF Cash Component 0.44%
Unknown 0.19%

Region Breakdown

Region Percentage
North America 92.31%
Europe 4.67%
Asia 1.16%
Asia-Pacific 0.72%
Middle East 0.55%
ETF Cash Component 0.44%
Latin America 0.15%

Market Tier Breakdown

Region Percentage
United States 92.31%
Developed Markets (ex-US) 5.95%
Emerging Markets 1.3%
ETF Cash Component 0.44%

Country Breakdown

Country Percentage
United States 92.31%
United Kingdom 1.82%
China 1.16%
Netherlands 1.14%
Spain 0.87%
Germany 0.76%
Japan 0.72%
Israel 0.55%
ETF Cash Component 0.44%
Mexico 0.15%
France 0.08%

FV Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same Category.

Expenses Ratio Analysis

ETF Average
ETF Wtd. Average
Category Average
Expense Ratio
Rank: 76 of 82
Category Low JDIV (0.12%)
Category High DFND (1.21%)

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 13 other ETFs in the All Cap Equities Category that are also eligible for commission free trading:

FV ESG Themes and Scores

FV does not have an ESG score. There are no ESG themes that map to this ETF.

FV Performance

This section shows how this ETF has performed relative to its peer group Category.

1 Week Return
Rank: 70 of 83
Category Low OLD (-3.78%)
Category High PVAL (1.95%)
4 Week Return
Rank: 70 of 82
Category Low OLD (-4.64%)
Category High QVAL (10.49%)
13 Week Return
Rank: 60 of 81
Category Low DWAQ (-8.35%)
Category High QVAL (16.79%)
26 Week Return
Rank: 60 of 81
Category Low ACT (-2.91%)
Category High PEXL (14.84%)
Year to Date Return
Rank: 51 of 79
Category Low FFHG (4.53%)
Category High ALFA (34.26%)
1 Year Return
Rank: 36 of 78
Category Low RENW (-11.44%)
Category High ALFA (22.78%)
3 Year Return
Rank: 18 of 48
Category Low FVL (11.12%)
Category High ARKW (141.23%)
5 Year Return
Rank: 15 of 33
Category Low EMLP (6.37%)
Category High ARKW (192.41%)

FV Fund Flows

This section compares the fund flows of this ETF to peers in the same Category.

1 Week Fund Flow
Rank: N/A
No Ranking Available
Category Low VUSE (‑$3.3 M)
Category High PFI ($22.4 M)
4 Week Fund Flow
Rank: 49 of 51
‑$16.3 M
Category Low CFO (‑$29.5 M)
Category High ARKW ($77.8 M)
13 Week Fund Flow
Rank: 63 of 65
‑$76.7 M
Category Low SDY (‑$135.8 M)
Category High EMLP ($93.1 M)
26 Week Fund Flow
Rank: 73 of 75
‑$147.9 M
Category Low CFO (‑$184.1 M)
Category High EMLP ($157.0 M)
Year to Date Fund Flow
Rank: 76 of 78
‑$182.6 M
Category Low CFO (‑$328.6 M)
Category High ARKK ($307.5 M)
1 Year Fund Flow
Rank: 77 of 78
‑$290.0 M
Category Low CFO (‑$377.2 M)
Category High SDY ($1,554.3 M)
3 Year Fund Flow
Rank: 80 of 80
‑$1,129.2 M
Category Low FV (‑$1,129.2 M)
Category High ARKK ($1,482.2 M)
5 Year Fund Flow
Rank: 4 of 81
$1,021.7 M
Category Low CVY (‑$878.5 M)
Category High EMLP ($1,769.7 M)

Brought to You by ETF Flows


The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of FV relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

FV Valuation

This section shows how the P/E multiple of this ETF compares to the peer group Category.

P/E Ratio
Rank: 55 of 78
Category Low VFVA (9.6)
Category High DWAQ (79.82)

FV Dividend

This section shows how the dividend yield of this ETF compares to the peer group Category.

Dividend Date
Annual Dividend Rate
Annual Dividend Yield
Rank: 73 of 77
Category Low SFYF (0.06%)
Category High ARKW (9.34%)

FV Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group Category.

5 Day Volatility
Rank: 36 of 83
Category Low NOCT (2.54%)
Category High ARKK (239.65%)
20 Day Volatility
Rank: 36 of 83
Category Low KOCT (3.54%)
Category High ARKW (24.08%)
50 Day Volatility
Rank: 52 of 81
Category Low VFMV (6.09%)
Category High PY (23.93%)
200 Day Volatility
Rank: 41 of 81
Category Low VFMV (8.93%)
Category High ARKK (25.44%)
Rank: 28 of 81
Category Low XLSY (-1.52)
Category High ARKK (1.69)
Standard Deviation
Rank: 40 of 76
Category Low FFHG (0.62%)
Category High DWAQ (9.68%)


  • 20 Day MA: $29.96
  • 60 Day MA: $29.73
  • MACD 15 Period: 0.16
  • MACD 100 Period: 0.22
  • Williams % Range 10 Day: 35.23
  • Williams % Range 20 Day: 21.38
  • RSI 10 Day: 57
  • RSI 20 Day: 55
  • RSI 30 Day: 53
  • Ultimate Oscillator: 61

Bollinger Brands

  • Lower Bollinger (10 Day): $29.89
  • Upper Bollinger (10 Day): $30.44
  • Lower Bollinger (20 Day): $29.42
  • Upper Bollinger (20 Day): $30.48
  • Lower Bollinger (30 Day): $28.83
  • Upper Bollinger (30 Day): $30.58

Support & Resistance

  • Support Level 1: n/a
  • Support Level 2: $30.07
  • Resistance Level 1: n/a
  • Resistance Level 2: $30.37


  • Stochastic Oscillator %D (1 Day): 48.03
  • Stochastic Oscillator %D (5 Day): 56.70
  • Stochastic Oscillator %K (1 Day): 52.32
  • Stochastic Oscillator %K (5 Day): 68.40

Fact Sheet

Fact sheets are issued by the ETF provider and framed by Information contained within the fact sheet is not guaranteed to be timely or accurate.

Emma/Mansi Image

Published March 1, 2016

The following article was not written by a human. It was written by an AI called Emma. Her bio can be found on her author page.

Artificial intelligence has come a long way, and while it may or may not replace humans, it is already providing exceptional support by augmenting human work in many industries. Emma collates news items and analyzes structured financial numbers as she spins out an article in 20 minutes. This is definitely an interesting milestone in AI. We’re just checking in to see if our readers like it. Do give us a shout on Twitter at @ETFdb or on Facebook.

Significant Exposure to Health Care

The First Trust Dorsey Wright Focus 5 ETF (FV C+) corresponds to the price and yield of the Dorsey Wright Focus Five Index. The fund will invest at least 90% of its net assets in ETFs that compose the index. The index is designed to provide targeted exposure to the five First Trust sector­-based ETFs that the index issuer believes offer the greatest potential to outperform the other ETFs. The index selects five ETFs based on relative price momentum and weights the constituent ETFs equally.

FV offers significant exposure to health care and consumer companies; health care accounts for more than 33% of exposure, while consumer names account for almost 40%. This means the ETF is prone to regulatory changes on the health care side ­as it relates to HMOs, Big Pharma and biotech. At the same time, the consumer names are impacted by global monetary policy. Over the course of the last 12 months, biotech, which is typically among the best performers in the health care sector, has seen its momentum slow.

This can be attributed to a variety of factors such as the exposé on Valeant, an increased regulatory focus on drug pricing in the U.S., and generic drug manufacturers outside the U.S. eating away market share, leaving little wiggle room for Big Pharma. The global consumer, meanwhile, remains resilient. However, significant headwinds in the form of slowing demand in China, rising interest rates in the U.S., a strong dollar, and a negative interest rate policy adopted by the ECB and the Japanese central bank have all been a drag on corporate earnings worldwide.

Political Rhetoric Against FV

The macro picture for FV is negative. Let’s look at several points worth considering. This year is an election year, and for some of FV’s constituents in the health care sector, the U.S. is by far the biggest market. With political rhetoric against FV’s largest constituents, ­owing to regulatory oversight on drug pricing, relationships with pharma retailers, and competition from generics, it appears that pre-election 2016 will bring a repeat of last year’s performance. While consumer names like Amazon (AMZN) and other sectors such as financials will probably offset some of the losses caused by the health care industry, the relative exposure of FV to health care is too large to ignore.

That takes us to FV’s financial ratios. FV has $3.4 billion in assets under management and has a yield of 0.16%, which is below market average. The ETF is at the midpoint of its all-time high of $25.51 and its all-time low of $17.75, hit in April 2014, just when it began trading. The fund’s expense ratio is 0.89%, which is significantly higher than other funds in its category. FV has a turnover ratio of 0%.

Weak Sell

I believe there are other opportunities in specific companies to which FV offers exposure. Given the lack of historical performance, an unclear theme, a recent runup, fees, and the headline risks, ­FV will be attractive below $20. With FV right now at $21.28, I believe it is a Weak Sell with a price target of $20.50.

Click here to read about Emma’s views on Microsoft, the ETFs QQQ, GDX, TLT, VOO and VTI, and the ETNs TVIX and VXX.

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at
© 2019 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.